Email updates

Keep up to date with the latest news and content from WAO Journal and BioMed Central.

This article is part of the supplement: 2nd WAO International Scientific Conference (WISC 2012), Abstracts

Open Access Open Badges Meeting abstract

Allergic diseases of the skin and drug allergies – 2006. Cord blood 25-hydroxyvitamin D3 and allergic disease during infancy

Anderson Phillip Jones1*, Debra Palmer1, Guicheng Zhang1 and Susan Prescott2

  • * Corresponding author: Anderson P Jones

Author Affiliations

1 School of Paediatrics and Child Health, University of Western Australia, Perth, Australia

2 Immunology, Princess Margaret Hospital, Australia

For all author emails, please log on.

World Allergy Organization Journal 2013, 6(Suppl 1):P96  doi:10.1186/1939-4551-6-S1-P96

The electronic version of this article is the complete one and can be found online at:

Published:23 April 2013

© 2013 Jones et al; licensee BioMed Central Ltd.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


There has been growing interest in vitamin D insufficiency as a predisposing factor for allergy development based on immunoregulatory properties and epidemiological studies. The aim of this study was to investigate the association between vitamin D exposure in utero and allergic outcomes in the first year of life.


Cord blood (CB) vitamin D was measured in 231 high risk infants from an Australian prospective birth cohort. CB 25(OH)D3 concentration was analysed in relation to maternal vitamin D intake and the development of infant eczema, allergen sensitization and IgE-mediated food allergy.


Maternal intake of supplemental vitamin D was significantly correlated with CB 25(OH)D3 concentration (rho = 0.244, p = 0.003) while dietary vitamin D did not influence CB levels. There was significant seasonal variation in CB 25(OH)D3 concentration suggesting that sunlight exposure was an important determinant. Lower CB vitamin D status was observed in infants that developed eczema (p = 0.018), and eczema was significantly more likely in those with concentrations < 50 nmol/L compared with >75 nmol/L (OR 2.66; 95% CI 1.24 – 5.72; p = 0.012). This association remained significant after adjustment for multiple confounding factors. The associations between CB 25(OH)D3 concentration and allergen sensitization, IgE-mediated food allergy and eczema severity (SCORAD) were not significant.


Reduced vitamin D status in pregnancy may be a risk factor for the development of eczema in the first year of life, reinforcing the need to explore the role of vitamin D exposure during development for disease prevention.